GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells

Cell Proliferation

Volumn 47, Issue 2, 2014, Pages 113-123

  Dolnikov, A ^a,b   Xu, N ^a,b   Shen, S ^a,b   Song, E ^a,b   Holmes, T ^b   Klamer, G ^b   O'Brien, T A ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 BROMOINDIRUBIN 3 OXIME; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CLONOGENESIS; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; FLOW CYTOMETRY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; ONCOGENE C MYC; ONCOGENE MYC; PHENOTYPE; UPREGULATION;

MUS;

ANIMALS; CELL ADHESION; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; FIBRONECTINS; GLYCOGEN SYNTHASE KINASE 3; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROGRAFTS; HUMANS; INDOLES; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; OXIMES; PROTEIN KINASE INHIBITORS; RECOMBINANT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84895929696     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12092     Document Type: Article

References (23)

1. Norkin M, Lazarus HM, Wingard JR. (2013) Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic? Bone Marrow Transplant. 48, 884-889.
2. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 363, 2091-2101.
3. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB et al. (2002) Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. 8, 368-376.
4. Dahlberg A, Delaney C, Bernstein ID (2011) Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117, 6083-6090.
5. Holmes T, Yan F, Ko KH, Nordon R, Song E, O'Brien TA et al. (2012) Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks. Cell Prolif. 45, 266-278.
6. Lento W, Congdon K, Voermans C, Kritzik M, Reya T. (2013) Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb. Perspect. Biol. 5, pii: a008011.
7. Kim JA, Kang YJ, Park G, Kim M, Park YO, Kim H et al. (2009) Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells 27, 1318-1329.
8. Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM et al. (2008) Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2, 274-283.
9. Ko KH, Holmes T, Palladinetti P, Song E, Nordon R, O'Brien TA et al. (2011) GSK-3beta inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression. Stem Cells 29, 108-118.
10. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F et al. (2001) Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J. Clin. Invest. 107, 199-206.
11. Shen S, Klamer G, Xu N, O'Brien TA, Dolnikov A (2013) GSK-3beta inhibition preserves naive T cell phenotype in bone marrow reconstituted mice. Exp. Hematol. 41(1016-1027), e1.
12. Novak A, Dedhar S (1999) Signaling through beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56, 523-537.
13. Holmes T, O'Brien TA, Knight R, Lindeman R, Shen S, Song E et al. (2008) Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth. Stem Cells 26, 1288-1297.
14. Zhai QL, Qiu LG, Li Q, Meng HX, Han JL, Herzig RH et al. (2004) Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Haematologica 89, 265-273.
15. Dolnikov A, Shounan Y, Millington M, Mackenzie K, Symonds G (1998) V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation. Leukemia 12, 542-553.
16. Miller PH, Cheung AM, Beer PA, Knapp DJ, Dhillon K, Rabu G et al. (2013) Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors. Blood 121, e1-e4.
17. Shen W, Bendall LJ, Gottlieb DJ, Bradstock KF (2001) The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp. Hematol. 29, 1439-1447.
18. Foguenne J, Di Stefano I, Giet O, Beguin Y, Gothot A (2009) Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica 94, 185-194.
19. Fleming JC, Bao F, Cepinskas G, Weaver LC (2010) Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes. Inflamm. Res. 59, 647-657.
20. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C et al. (2008) Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J. Clin. Invest. 118, 3609-3618.
21. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA (2002) The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21, 3414-3421.
22. Garcia-Hernandez B, Castellanos A, Lopez A, Orfao A, Sanchez-Garcia I (1997) Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells. Proc. Natl. Acad. Sci. USA 94, 13239-13244.
23. Holmes T, O'Brien TA, Knight R, Lindeman R, Symonds G, Dolnikov A (2008) The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia. Curr. Med. Chem. 15, 1493-1499.